Delivery Order SPE2DB25D3006-SPE2DB26FXHKD
Award Date 11/4/25
Potential Completion Date 11/26/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Envarsus XR 1 mg tablets (30-count units) under a firm fixed-price contract valued at $1,165.05. The award was made on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,811.00 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on October 29, 2025, with completion targeted for November 20, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for a specialized immunosuppressant medication. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $7,733.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on September 22, 2025, with completion scheduled for October 14, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a $2,148.10 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Envarsus XR 1 mg tablets (100 count). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by November 24, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Envarsus XR is a brand-name immunosuppressant medication used primarily in transplant patients to...
- The Defense Logistics Agency has awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100-count packaging). This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by October 21, 2025. The contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania, where AmerisourceBergen maintains operations as a primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packaging) with a ceiling value of $1,227.78. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on November 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,361.58 for Envarsus XR 1 mg tablets (30-count supply) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Envarsus XR is an extended-release immunosuppressant medication used primarily in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packaging) with a ceiling value of $1,553.40. This is a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, utilizing no set-aside designation. The contract represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $1,165.05 to AmerisourceBergen Drug Corp for 30 tablets of Envarsus XR 1 mg on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitively awarded transaction under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100 units, with a ceiling value of $1,288.86. This is a firm fixed price delivery order with an ultimate completion date of October 9, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...